Dill tablet: A potential antioxidant and anti-diabetic medicine

Asian Pacific Journal of Tropical Biomedicine

Volumn 5, Issue 9, 2015, Pages 720-727

  Abbasi Oshaghi, Ebrahim ^a   Tavilani, Heidar ^a   Khodadadi, Iraj ^a   Goodarzi, Mohammad Taghi ^a,b  

^a HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anethum graveolens; Antioxidants; Dill; Flavonoids; Herbal medicine; Hypoglycemic agents

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALKALOID; ANETHUM GRAVEOLENS EXTRACT; ANTHOCYANIN; CARBONYL DERIVATIVE; FLAVONOID; FLAVONOL; FRUCTOSAMINE; PHENOL DERIVATIVE; PLANT EXTRACT; SAPONIN; TANNIN; THIOL GROUP; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DILL; FLUOROMETRY; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLYCATION; HYPOLIPEMIA; IN VIVO STUDY; IRAN; MALE; MEDICINAL PLANT; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT;

EID: 84955212006     PISSN: 22211691     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apjtb.2015.06.012     Document Type: Article

References (40)

1. Mishra N. Haematological and hypoglycemic potential Anethum graveolens seeds extract in normal and diabetic Swiss albino mice. Vet World 2013, 6:502-507.
2. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
3. Rashidlamir A., Gholamian S., Javaheri A.H., Dastani M. The effect of 4-weeks aerobic training according with the usage of Anethum graveolens on blood sugar and lipoproteins profile of diabetic women. Ann Biol Res 2012, 3:4313-4319.
4. Kalousova M., Skrha J., Zima T. Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res 2002, 51:597-604.
5. Madani H., Ahmady Mahmoodabady N., Vahdati A. Effects of hydroalchoholic extract of Anethum graveolens (Dill) on plasma glucose an lipid levels in diabetes induced rats. J Diabetes Metab Disord 2005, 5:139.
6. Panda S. The effect of Anethum graveolens L. (dill) on corticosteroid induced diabetes mellitus: involvement of thyroid hormones. Phytother Res 2008, 22:1695-1697.
7. Sushruta K., Satyanarayana S., Srinivas N., Raja Sekhar J. Evaluation of the blood-glucose reducing effects of aqueous extracts of the selected umbelliferous fruits used in culinary practices. Trop J Pharm Res 2006, 5:613-617.
8. Ramadan M.M., Abd-Algader N.A., El-Kamali H.H., Ghanem K.Z., Farrag A.R.H. Volatile compounds and antioxidant activity of the aromatic herb Anethum graveolens. J Arab Soc Med Res 2013, 8:79-88.
9. Bahramikia S., Yazdanparast R. Antioxidant and free radical scavenging activities of different fractions of Anethum graveolens leaves using in vitro models. Pharmacologyonline 2008, 2:219-233.
10. Priecina L., Karklina D. Natural antioxidant changes in fresh and dried spices and vegetables. World Acad Sci Eng Technol 2014, 8:979-981.
11. Mobasseri M., Payahoo L., Ostadrahimi A., Khaje bishak Y., Jafarabadi M.A., Mahluji S. Anethum graveolens supplementation improves insulin sensitivity and lipid abnormality in type 2 diabetic patients. Pharm Sci 2014, 20:40-45.
12. Jana S., Shekhawat G.S. Anethum graveolens: an Indian traditional medicinal herb and spice. Pharmacogn Rev 2010, 4:179-184.
13. Haghighi B., Kharazizadeh M., Attar M.A. Possible involvement of hepatic phosphatidate phosphohydrolase in the mechanisms of actions of certain antilipemic drugs in rats. Iran J Pharm Res 2007, 6:273-278.
14. Hasani-Ranjbar S., Larijani B., Abdollahi M. A systematic review of Iranian medicinal plants useful in diabetes mellitus. Arch Med Sci 2008, 4:285-292.
15. Sahib A.S., Mohammad I.H., Al-Gareeb A.I. Effects of Anethum graveolens leave powder on lipid profile in hyperlipidemic patients. Spatula DD 2012, 2:153-158.
16. Mansouri M., Nayebi N., Keshtkar A., Hasani-Ranjbar S., Taheri E., Larijani B. The effect of 12 weeks Anethum graveolens (dill) on metabolic markers in patients with metabolic syndrome; a randomized double blind controlled trial. Daru 2012, 20:47.
17. Setorki M., Rafieian-Kopaei M., Merikhi A., Heidarian E., Shahinfard N., Ansari R., et al. Suppressive impact of Anethum graveolens consumption on biochemical risk factors of atherosclerosis in hypercholesterolemic rabbits. Int J Prev Med 2013, 4:889-895.
18. Salmanian S., Sadeghi Mahoonak A.R., Alami M., Ghorbani M. Phenolic content, antiradical, antioxidant, and antibacterial properties of hawthorn (Crataegus elbursensis) seed and pulp extract. J Agric Sci Technol 2014, 16:343-354.
19. Dadashpour M., Rasooli I., Sefidkon F., Rezaei M.B., Darvish Alipour Astaneh S. Lipid peroxidation inhibition, superoxide anion and nitric oxide radical scavenging properties of Thymus daenensis and Anethum graveolens essential oils. J Med Plants 2011, 10:109-120.
20. Güder A., Korkmaz H. Evaluation of in-vitro antioxidant properties of hydroalcoholic solution extracts Urtica dioica L., Malva neglecta Wallr. and their mixture. Iran J Pharm Res 2012, 11:913-923.
21. Kumaran A., Joel Karunakaran R. In vitro antioxidant activities of methanol extracts of five Phyllanthus species from India. LWT Food Sci Technol 2007, 40:344-352.
22. Stankevičius M., Akuneca I., Jãkobsone I., Maruška A. Analysis of phenolic compounds and radical scavenging activities of spice plants extracts. Food Chem Technol 2010, 44:85-91.
23. Ahmad M.S., Pischetsrieder M., Ahmed N. Aged garlic extract and S-allyl cysteine prevent formation of advanced glycation endproducts. Eur J Pharmacol 2007, 561:32-38.
24. Mbaebie B.O., Edeoga H.O., Afolayan A.J. Phytochemical analysis and antioxidants activities of aqueous stem bark extract of Schotia latifolia Jacq. Asian Pac J Trop Biomed 2012, 2:118-124.
25. Caengprasath N., Ngamukote S., Mäkynen K., Adisakwattana S. The protective effects of pomelo extract (Citrus grandis L. Osbeck) against fructose-mediated protein oxidation and glycation. EXCLI J 2013, 12:491-502.
26. Abedini A., Schmidt A.M. Mechanisms of islet amyloidosis toxicity in type 2 diabetes. FEBS Lett 2013, 587:1119-1127.
27. Sakai M., Oimomi M., Kasuga M. Experimental studies on the role of fructose in the development of diabetic complications. Kobe J Med Sci 2002, 48:125-136.
28. Gulçin I. Antioxidant activity of caffeic acid (3, 4-dihydroxycinnamic acid). Toxicology 2006, 217:213-220.
29. Pietta P.G. Flavonoids as antioxidants. J Nat Prod 2000, 63:1035-1042.
30. Pramod K., Devala R.G., Lakshmayya Ramachandra SS. Nephroprotective and nitric oxide scavenging activity of tubers of Momordica tuberosa in rats. Avicenna J Med Biotechnol 2011, 3:87-93.
31. Raghuveer C., Tandon R.V. Consumption of functional food and our health concerns. Pak J Physiol 2009, 5:76-83.
32. Agrawal R., Sethiya N.K., Mishra S.H. Antidiabetic activity of alkaloids of Aerva lanata roots on streptozotocin-nicotinamide induced type-II diabetes in rats. Pharm Biol 2013, 51:635-642.
33. 2 as solvent. Food Res Int 2013, 50:617-624.
34. Serrano J., Puupponen-Pimia R., Dauer A., Aura A.M., Saura-Calixto F. Tannins: current knowledge of food sources, intake, bioavailability and biological effects. Mol Nutr Food Res 2009, 53:S310-S329.
35. Yin X., Zhang Y., Wu H., Zhu X., Zheng X., Jiang S., et al. Protective effects of astragalus saponin I on early stage of diabetic nephropathy in rats. J Pharmacol Sci 2004, 95:256-266.
36. Cohen M.P. Intervention strategies to prevent pathogenetic effects of glycated albumin. Arch Biochem Biophys 2003, 419:25-30.
37. Singh R., Kaur N., Kishore L., Gupta G.K. Management of diabetic complications: a chemical constituents based approach. J Ethnopharmacol 2013, 150:51-70.
38. Singh R., Barden A., Mori T., Beilin L. Advanced glycation end-products: a review. Diabetologia 2001, 44:129-146.
39. Nagai R., Murray D.B., Metz T.O., Baynes J.W. Chelation: a fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications. Diabetes 2012, 61:549-559.
40. Mirhosseini M., Baradaran A., Rafieian-Kopaei M. Anethum graveolens and hyperlipidemia: a randomized clinical trial. J Res Med Sci 2014, 19:758-761.